Chinese e-commerce giant "Qwen Team" of AI researchers has done it again. After a busy summer in which the AI lab released a whole fleet of new open source AI models with support for English and ...

First chemotherapy-free trial combining ANKTIVA, an IL-15 agonist, natural killer (NK) cell therapy, and Optune immune-stimulating device for patients with glioblastoma (GBM) brain tumors who have ...

Nvidia (NVDA) stock dropped on Thursday morning as Wall Street digested second quarter earnings that beat on the top and bottom lines, though its data center revenue came in just shy of analyst ...

CARSON CITY, Nev. — A massive cyberattack has crippled Nevada’s state government since Sunday, with state officials confirming that some data has been moved outside of the network by "malicious actors ...

After launching GPT-5 a few days ago, OpenAI CEO Sam Altman introduced exciting new GPT-5 response modes on August 13. Users can now select from three distinct response settings- Auto, Fast, and ...

WASHINGTON (7News) — President Donald Trump is escalating his crime crackdown in the nation’s capital, signing two new executive orders that further expand federal control over public safety in the ...

Pfizer has revealed that its much-anticipated selective oestrogen receptor degrader (SERD) vepdegestrant for breast cancer missed the mark for a key endpoint in its first phase 3 trial readout.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...